In vivo visualization of prostate-specific membrane antigen in glioblastoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 42, Issue 1, 2015, Pages 170-171

  Schwenck, Johannes ^a   Tabatabai, Ghazaleh ^a,b   Skardelly, Marco ^a   Reischl, Gerhald ^a   Beschorner, Rudi ^a   Pichler, Bernd ^a   la Fougère, Christian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 68; PROSTATE SPECIFIC MEMBRANE ANTIGEN; FLUORODEOXYGLUCOSE F 18; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; MEMBRANE ANTIGEN; RADIOPHARMACEUTICAL AGENT;

ANTIGEN EXPRESSION; ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER GROWTH; CONTRAST ENHANCEMENT; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; TREATMENT PLANNING; VASCULARIZATION; DIAGNOSTIC USE; HODGKIN DISEASE; METABOLISM; SCINTISCANNING; TISSUE DISTRIBUTION;

ANTIGENS, SURFACE; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; GLUTAMATE CARBOXYPEPTIDASE II; HODGKIN DISEASE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 84912021339     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2921-5     Document Type: Article

References (5)

1. Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005;5:436–46. doi:10.1038/nrc1627.
2. Wernicke AG, Edgar MA, Lavi E, Liu H, Salerno P, Bander NH, et al. Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. Arch Pathol Lab Med. 2011;135:1486–9. doi:10.5858/arpa.2010-0740-OA.
3. Tagawa ST, Milowsky MI, Morris M, Vallabhajosula S, Christos P, Akhtar NH, et al. Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res. 2013;19:5182–91. doi:10.1158/1078-0432.CCR-13-0231.
4. Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, et al. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. 2014;14:26. doi:10.1186/1475-2867-14-26.
5. Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2014;41:11–20. doi:10.1007/s00259-013-2525-5.